MIRM - Mirum Pharmaceuticals, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$153.20
DETAILS
HIGH:
$200.00
LOW:
$130.00
MEDIAN:
$149.00
CONSENSUS:
$153.20
UPSIDE:
84.36%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 27,879 | $3.3M | 0.0% | -139,610 | DECREASED |
| Laffont | 9,916 | $1.2M | 0.1% | -- | UNCHANGED |
| Wood | 6,600 | $772,662 | 0.0% | -- | UNCHANGED |
| Greenblatt | 2,385 | $279,212 | 0.0% | -759 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-10-16 | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | M-Exempt | 16,112 | $19.24 | $310K |
| 2026-10-09 | Myers Robert Paul | officer: Chief Medical Officer | A-Award | 40,000 | $86.01 | $3.4M |
| 2026-10-09 | Myers Robert Paul | officer: Chief Medical Officer | A-Award | 25,000 | -- | -- |
| 2026-10-06 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 6,892 | $15.87 | $109K |
| 2026-10-06 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 5,305 | $19.19 | $102K |
| 2026-09-21 | Myers Robert Paul | officer: Chief Medical Officer | ? | -- | -- | -- |
| 2026-09-11 | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | M-Exempt | 18,333 | -- | -- |
| 2026-09-14 | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | SELL | 9,943 | $98.37 | $978K |
| 2026-09-02 | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | SELL | 658 | $100.00 | $66K |
| 2026-09-01 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 30,000 | $2.94 | $88K |
| 2026-09-01 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | SELL | 8,312 | $98.08 | $815K |
| 2026-09-01 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | SELL | 21,688 | $98.91 | $2.1M |
| 2026-08-18 | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | M-Exempt | 40,000 | $6.27 | $251K |
| 2026-08-18 | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | SELL | 40,000 | $100.00 | $4.0M |
| 2026-08-11 | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | SELL | 6,001 | $99.90 | $600K |
| 2026-08-10 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 20,000 | $2.94 | $59K |
| 2026-08-10 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | SELL | 6,017 | $99.25 | $597K |
| 2026-08-10 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | SELL | 11,683 | $98.51 | $1.2M |
| 2026-08-10 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | SELL | 2,300 | $100.14 | $230K |
| 2026-08-03 | Howe Jolanda | officer: SVP, GLOBAL CONTROLLER | SELL | 1,840 | $105.29 | $194K |
| 2026-07-06 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | SELL | 12,134 | $121.65 | $1.5M |
| 2026-07-06 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | SELL | 4,181 | $122.34 | $512K |
| 2026-07-06 | Peetz Christopher | director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 20,000 | $2.94 | $59K |
| 2026-07-06 | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | SELL | 1,048 | $122.43 | $128K |
| 2026-07-06 | BJERKHOLT ERIC | officer: CHIEF FINANCIAL OFFICER | SELL | 300 | $124.94 | $37K |